News

In the News
More
Q&A with Pulmocide CEO Garth Rapeport – Why Pulmocide is developing targeted lung therapy.
7 August 2019
Q&A with Pulmocide CEO Garth Rapeport – Why Pulmocide is developing targeted lung therapy. Read More
How to spot the hidden gem investment funds
29 June 2019
How to spot the hidden gem investment funds Read More
CardioFocus lands $55M in funding for product launches
28 May 2019
CardioFocus lands $55M in funding for product launches Read More
UCB announces NAYZILAM® (midazolam) nasal spray now approved by FDA to treat intermittent, stereotypic episodes of frequent seizure activity in people living with epilepsy in the U.S.
20 May 2019
UCB announces NAYZILAM® (midazolam) nasal spray now approved by FDA to treat intermittent, stereotypic episodes of frequent seizure activity in people living with epilepsy in the U.S. Read More
Press Releases
More
Deciphera Pharmaceuticals Announces Submission of New Drug Application to U.S. FDA for Ripretinib in Patients with Advanced Gastrointestinal Stromal Tumors
16 December 2019
Deciphera Pharmaceuticals Announces Submission of New Drug Application to U.S. FDA for Ripretinib in Patients with Advanced Gastrointestinal Stromal Tumors Read More
American Well® Acquires Aligned Telehealth to Expand Behavioral Health Virtual Care
7 November 2019
American Well® Acquires Aligned Telehealth to Expand Behavioral Health Virtual Care Read More
Artios Pharma, MD Anderson and ShangPharma Announce In-Licensing Agreement for DNA Damage Response Inhibitor
6 November 2019
Artios Pharma, MD Anderson and ShangPharma Announce In-Licensing Agreement for DNA Damage Response Inhibitor Read More
Healthify Raises $16M to Integrate Health and Social Services
5 November 2019
Healthify Raises $16M to Integrate Health and Social Services Read More
Press Contacts
Michael-Jon Romano
Sommerfield Communications
T: (212) 255-8386
Events
More

View all events